IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Tamarack Advisers, LP

Q4 2019 Holdings

Filed 2020-02-11 | 29 holdings | $65.0M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Bio-Rad Laboratories(BIO)Equity090572207$36.7M100,00056.5%
Atricure Inc(ATRC)Equity04963C209$27.9M860,00043.0%
Medtronic PLCEquity585055106$43.8K385,0000.1%
Allscripts Healthcare Soluti(MDRX)Equity01988P108$35.2K3,650,0000.1%
Pacira Biosciences Inc(PCRX)Equity695127100$27.8K622,5000.0%
Quest Diagnostics Inc(DGX)Equity74834L100$25.7K245,0000.0%
Hologic Inc(HOLX)Equity436440101$24.6K475,0000.0%
Iveric BIO Inc(OPHTEUR)Equity46583P102$21.6K2,650,0000.0%
Zimmer Biomet Holdings Inc(ZBH)Equity98956P102$18.6K125,0000.0%
Stericycle Inc(SRCLEUR)Equity858912108$18.6K300,0000.0%
Johnson & Johnson(JNJ)Equity478160104$18.0K125,0000.0%
Phreesia Inc(PHR)Equity71944F106$17.5K660,0000.0%
Portola Pharmaceuticals IncEquity737010108$14.3K595,0000.0%
Integer Holdings Corp(ITGR)Equity45826H109$13.4K165,0000.0%
United Therapeutics Corp(UTHR)Equity91307C102$13.1K151,4000.0%
ICU Medical Inc(ICUI)Equity44930G107$13.0K70,0000.0%
Lantheus Holdings Inc(LNTH)Equity516544103$12.5K650,0000.0%
Rigel Pharmaceuticals Inc(RIGLUSD)Equity766559603$11.8K5,750,0000.0%
Mylan NVEquity628530107$9.1K450,0000.0%
Optinose IncEquity68404V100$8.6K1,050,0000.0%
Radnet Inc(RDNT)Equity750491102$8.3K400,0000.0%
Streamline Health SolutionsEquity86323X106$6.0K4,305,8820.0%
Inogen Inc(INGN)Equity45780L104$5.0K75,0000.0%
Nevro Corp(NVROEUR)Equity64157F103$4.7K40,0000.0%
Correvio Pharma CorpEquity22026V105$1.0K2,500,0000.0%
SPY US 01/17/20 P310PutListed Option78462F953$5128,0000.0%
CRL US 01/17/20 C140CallListed Option159864907$2792180.0%
JNJ US 01/17/20 C140CallListed Option478160904$1252500.0%
HAE US 01/17/20 C125CallListed Option405024900$245000.0%